We are live on
!
Find out more
SFI
Susquehanna Fundamental Investments Portfolio holdings
AUM
$2.67B
1-Year Est. Return
21.74%
This Fund
S&P 500
This Quarter
Est. Return
+8.02%
1 Year Est. Return
+21.74%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.74B
AUM Growth
-$1.55B
(-36%)
Cap. Flow
-$1.69B
Cap. Flow
% of AUM
-61.72%
Top 10 Holdings %
Top 10 Hldgs %
17.93%
Holding
941
New
2
Increased
1
Reduced
412
Closed
307
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Knife River
KNF
|
+$2.44M |
| 2 |
Baytex Energy
BTE
|
+$581K |
| 3 |
Bank of Montreal
BMO
|
+$32.6K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$52.9M |
| 2 |
Ovintiv
OVV
|
+$43.5M |
| 3 |
Blackrock
BLK
|
+$37.1M |
| 4 |
Goldman Sachs
GS
|
+$34.4M |
| 5 |
Deere & Co
DE
|
+$32.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.84% |
| 2 | Industrials | 13.67% |
| 3 | Financials | 13.46% |
| 4 | Consumer Discretionary | 10.34% |
| 5 | Materials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Accuray
ARAY
$33.4M
| $113K | ﹤0.01% |
29,219
| – | – |
|
602
Eldorado Gold
EGO
$10.4B
| $111K | ﹤0.01% |
11,000
| – | – |
|
|
NGM
603
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $110K | ﹤0.01% |
42,353
| – | – |
|
604
Kearny Financial
KRNY
$600M
| $107K | ﹤0.01% |
15,222
-1,888
| -11% | -$14K |
|
605
Caribou Biosciences
CRBU
$169M
| $105K | ﹤0.01% |
24,752
-18,627
| -43% | -$83.7K |
|
606
DHI Group
DHX
$166M
| $102K | ﹤0.01% |
26,549
-32,403
| -55% | -$120K |
|
607
Evolution Petroleum
EPM
$134M
| $101K | ﹤0.01% |
12,549
| – | – |
|
608
Champions Oncology
CSBR
$68.8M
| $97.2K | ﹤0.01% |
15,449
-5,170
| -25% | -$26.7K |
|
609
TherapeuticsMD
TXMD
$24.1M
| $97.1K | ﹤0.01% |
23,573
-14,469
| -38% | -$56.8K |
|
|
NINE
610
DELISTED
Nine Energy Service
NINE
| $96.1K | ﹤0.01% |
25,084
-47,649
| -66% | -$184K |
|
611
Nektar Therapeutics
NKTR
$2.57B
| $88.5K | ﹤0.01% |
10,252
| – | – |
|
|
OPI
612
DELISTED
Office Properties Income Trust
OPI
| $81.5K | ﹤0.01% |
10,582
-13,321
| -56% | -$101K |
|
613
Western New England Bancorp
WNEB
$282M
| $76.7K | ﹤0.01% |
13,136
-33,341
| -72% | -$216K |
|
614
Fulcrum Therapeutics
FULC
$284M
| $74.6K | ﹤0.01% |
22,594
-18,940
| -46% | -$55.6K |
|
|
NVTA
615
DELISTED
Invitae Corporation
NVTA
| $72.5K | ﹤0.01% |
64,200
| – | – |
|
616
SIGA Technologies
SIGA
$206M
| $67K | ﹤0.01% |
13,262
-23,397
| -64% | -$133K |
|
|
TCS
617
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $63.8K | ﹤0.01% |
1,355
-251
| -16% | -$11.2K |
|
|
GRTS
618
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $59.6K | ﹤0.01% |
30,547
| – | – |
|
|
ESPR
619
DELISTED
Esperion Therapeutics
ESPR
| $58.1K | ﹤0.01% |
41,809
| – | – |
|
620
Amneal Pharmaceuticals
AMRX
$6.15B
| $52.9K | ﹤0.01% |
17,064
-42,400
| -71% | -$90.3K |
|
621
GrafTech
EAF
$201M
| $52.5K | ﹤0.01% |
1,042
-3,737
| -78% | -$174K |
|
622
ADMA Biologics
ADMA
$2.19B
| $49.1K | ﹤0.01% |
13,310
| – | – |
|
623
C4 Therapeutics
CCCC
$480M
| $48.3K | ﹤0.01% |
17,572
| – | – |
|
624
Barnes & Noble Education
BNED
$417M
| $46.1K | ﹤0.01% |
366
-584
| -61% | -$81.7K |
|
625
Polar Power
POLA
$7.13M
| $45.5K | ﹤0.01% |
4,961
-1,115
| -18% | -$9.89K |
|
Similar funds
TCAM
VA
MMEA
PCIG
MG
CCM
ACM
LP
Susquehanna Fundamental Investments's Q2 2023 Portfolio in Review
As of Q2 2023, Susquehanna Fundamental Investments held 941 positions worth $2.74B, down 36% from $4.29B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Susquehanna Fundamental Investments withdrew a net $1.69B in Q2 2023, closing 307 positions and reducing 412 holdings. Its most notable exit was Ovintiv, an estimated $43.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 18% a quarter earlier, followed by Industrials and Financials.
Against the trend, Susquehanna Fundamental Investments opened a new position in Knife River worth $2.5M.
- Susquehanna Fundamental Investments's largest Q2 2023 buy was Knife River: 57,394 shares worth $2.5M.
- Susquehanna Fundamental Investments added most to Bank of Montreal in Q2 2023, an estimated $32.6K increase.
- Susquehanna Fundamental Investments's biggest Q2 2023 reduction was Starbucks, cutting an estimated $52.9M.
- Susquehanna Fundamental Investments fully exited Ovintiv in Q2 2023, selling an estimated $43.5M.
- Susquehanna Fundamental Investments's ten largest holdings make up 18% of its $2.74B portfolio in Q2 2023.
- Susquehanna Fundamental Investments opened 2 new positions and closed 307 in Q2 2023.
- Susquehanna Fundamental Investments's portfolio value fell 36% quarter-over-quarter to $2.74B.
Based on Susquehanna Fundamental Investments's 13F filing for Q2 2023, filed 11 Aug 2023.